Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke

This study is looking at how well a smartwatch app and behavioral support can help people who have had a stroke improve their arm use. The smartwatch apps measure how much you move your arm and how varied your movements are. The behavioral support uses "Motivational Interviewing," a technique to help you stick with therapy. To join, you need to be between 18 and 85 years old, have experienced a stroke more than six months ago, and have some weakness in one arm. The main goal is to see if these interventions improve how much you use your arm. The study is currently unclear about its recruitment status and plans to enroll 32 participants.

Study design
This is a randomized controlled trial, meaning participants will be assigned by chance to different groups. It aims to enroll 32 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your arm movement variability will be measured from when you join until the end of treatment and for a follow-up period of 9 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07042152

Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke

Recruiting
NAAges 18–84InterventionalTreatment
University of California, Irvine
~32 participants
Updated 2025-08-19 on ClinicalTrials.gov
What's tested:Smartwatch App for Movement VariabilitySmartwatch App for Active TimeMotivational Interviewing (Within Subjects)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Variability Measurement
Measured over From enrollment to the end of treatment and follow up measurement (9 weeks)
Chronic Stroke Patients

NCT07042152

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of California Irvine

    Irvine, Californiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • David Reinkensmeyer, PhD · PRINCIPAL_INVESTIGATOR · University of California, Irvine

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 to 85 years of age
Experienced a single or multiple, ischemic or hemorrhagic stroke, with unilateral weakness, over six months previously
An ability to score at least 3 blocks on the Box and Block Test. BBT score of the affected arm is at least 5% worse than that present with the unaffected arm.
Absence of major depression, as defined by DSM V criteria or a score on the Geriatric Depression Scale \< 10.

Exclusion

Any substantial decrease in alertness, language reception, or attention
Single or multiple, ischemic or hemorrhagic stroke less than 6 months ago
Severe muscle tone at the upper extremity (score ≥ 3 on the Modified Ashworth Spasticity scale)
Pregnant or lactating
Advanced liver, kidney, cardiac, or pulmonary disease
Coexistent major neurological disease
Coexistent major psychiatric disease
Plans to alter any current participation in other rehabilitation therapy in the time period of the study
A terminal medical diagnosis consistent with survival \< 1 year
A history of significant alcohol or drug abuse in the prior 3 years
Current enrollment in another study related to stroke or stroke recovery
Any other medical contraindication to participation in the study, as evaluated by our team physician.
Visual Analog of Pain Scale Score of 7 or greater
  • Variability MeasurementFrom enrollment to the end of treatment and follow up measurement (9 weeks)

    The amount of variability for the impaired upper extremity will be quantified by the variety of movements performed.